Northwestern Mutual Wealth Management Co. Buys Shares of 71,501 Kenvue Inc. $KVUE

Northwestern Mutual Wealth Management Co. purchased a new position in shares of Kenvue Inc. (NYSE:KVUE) in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 71,501 shares of the company’s stock, valued at approximately $1,366,000.

Other hedge funds also recently made changes to their positions in the company. Johnson Financial Group Inc. acquired a new position in Kenvue during the second quarter worth $26,000. CoreCap Advisors LLC increased its stake in Kenvue by 64.9% in the 2nd quarter. CoreCap Advisors LLC now owns 1,502 shares of the company’s stock valued at $29,000 after buying an additional 591 shares during the last quarter. Elyxium Wealth LLC bought a new stake in Kenvue during the 4th quarter worth about $26,000. Physician Wealth Advisors Inc. lifted its position in Kenvue by 67.5% during the 4th quarter. Physician Wealth Advisors Inc. now owns 1,533 shares of the company’s stock worth $26,000 after buying an additional 618 shares in the last quarter. Finally, MV Capital Management Inc. acquired a new position in shares of Kenvue during the 4th quarter worth about $28,000. 97.64% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the company. Weiss Ratings upgraded Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a report on Monday, June 15th. Wall Street Zen cut Kenvue from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. UBS Group reduced their price target on Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a research report on Tuesday, August 11th. Barclays raised their price target on Kenvue from $18.00 to $19.00 and gave the company an “equal weight” rating in a research note on Tuesday, July 21st. Finally, Zacks Research cut Kenvue from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, July 7th. Three equities research analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average price target of $19.27.

Kenvue Trading Down 0.4%

Kenvue stock opened at $19.34 on Wednesday. Kenvue Inc. has a 52 week low of $14.02 and a 52 week high of $21.40. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.71 and a current ratio of 1.01. The stock has a market capitalization of $37.16 billion, a P/E ratio of 22.24, a PEG ratio of 1.39 and a beta of 0.47. The stock has a 50-day simple moving average of $19.10 and a 200 day simple moving average of $18.22.

Kenvue (NYSE:KVUE) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.31 earnings per share for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.01). Kenvue had a return on equity of 21.22% and a net margin of 10.76%.The business had revenue of $3.96 billion for the quarter, compared to analyst estimates of $3.97 billion. During the same period last year, the firm earned $0.29 EPS. Kenvue’s quarterly revenue was up 3.0% compared to the same quarter last year. Analysts expect that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, August 26th. Investors of record on Wednesday, August 12th will be issued a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a dividend yield of 4.3%. The ex-dividend date of this dividend is Wednesday, August 12th. This is a boost from Kenvue’s previous quarterly dividend of $0.21. Kenvue’s payout ratio is presently 96.55%.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.